Anaptysbio (ANAB) Gains from Investment Securities (2016 - 2025)
Historic Gains from Investment Securities for Anaptysbio (ANAB) over the last 9 years, with Q3 2025 value amounting to -$22.5 million.
- Anaptysbio's Gains from Investment Securities fell 4607.8% to -$22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.0 million, marking a year-over-year decrease of 223.44%. This contributed to the annual value of $7.5 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Anaptysbio's Gains from Investment Securities is -$22.5 million, which was down 4607.8% from -$19.6 million recorded in Q2 2025.
- Anaptysbio's 5-year Gains from Investment Securities high stood at $40.2 million for Q4 2024, and its period low was -$24.8 million during Q2 2024.
- Moreover, its 5-year median value for Gains from Investment Securities was -$4.6 million (2022), whereas its average is -$2.0 million.
- Examining YoY changes over the last 5 years, Anaptysbio's Gains from Investment Securities showed a top increase of 27306.27% in 2024 and a maximum decrease of 46847.18% in 2024.
- Anaptysbio's Gains from Investment Securities (Quarter) stood at $20.7 million in 2021, then decreased by 18.51% to $16.9 million in 2022, then fell by 22.14% to $13.1 million in 2023, then skyrocketed by 206.19% to $40.2 million in 2024, then crashed by 156.03% to -$22.5 million in 2025.
- Its last three reported values are -$22.5 million in Q3 2025, -$19.6 million for Q2 2025, and -$18.1 million during Q1 2025.